Source comparison
Best Peptides for Injury Recovery: Mechanism Comparison
BPC-157 VEGFR-2 agonist. Promotes angiogenesis and fibroblast recruitment Tendon, ligament, and low-vascular-density injuries 200–500 mcg per dose, daily or twice daily Start within 48 hours, continue 14–21 days Strongest evidence for vascular-limited injuries
This comparison does not assign a generated winner or score.
- BPC-157
- VEGFR-2 agonist. Promotes angiogenesis and fibroblast recruitment
- Tendon, ligament, and low-vascular-density injuries
- 200–500 mcg per dose, daily or twice daily
- Start within 48 hours, continue 14–21 days
- Strongest evidence for vascular-limited injuries; stable and well-tolerated in models
- TB-500
- Actin upregulation. Enhances cell migration and extracellular matrix synthesis
- Muscle tears, fascia injuries, satellite cell activation
- 2–5 mg per dose, twice weekly
- Start day 3–7, continue through day 21
- Best for injuries requiring rapid fibroblast infiltration; less effective if started late
- GHK-Cu
- MMP regulation. Remodels scar tissue and improves collagen type I-to-type III ratio
- Remodeling phase, scar reduction, range-of-motion restoration
- 1–3 mg per dose, twice weekly
- Start week 3, continue through week 10–12
- Improves tissue quality during late-stage healing; minimal effect if used too early